Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
Economics (2014) - Comments
pubmed: 24515272  doi: 10.1158/1055-9965.epi-13-1180  issn: 1538-7755  issn: 1055-9965 

Jacqueline Fontugne, Daniel Lee, Chiara Cantaloni, Christopher E. Barbieri, Orazio Caffo, Esther Hanspeter, Guido Mazzoleni, Paolo Dalla Dalla Palma, Mark A. Rubin, Giovanni Fellin, Juan Miguel Mosquera, Mattia Barbareschi, Francesca Demichelis